Ryan Weldon, MD
Internal Medicine · Birmingham, ALNPI 1568724870
Payments from drug & device makers
Across 1,555 payments — averaging $294.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$205K
- AstraZeneca$136K
- Boehringer Ingelheim$45K
- Amgen$40K
- Novartis$16K
- AbbVie$6K
- plus $10K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 255 | $205,456 |
| AstraZeneca(2 entities) | 163 | $135,624 |
| Boehringer Ingelheim | 62 | $44,795 |
| Amgen(2 entities) | 217 | $39,854 |
| Novartis | 104 | $16,203 |
| AbbVie | 214 | $5,636 |
| UCB, Inc. | 93 | $1,573 |
| Johnson & Johnson | 66 | $1,545 |
| Pfizer | 98 | $1,445 |
| E.r. Squibb & Sons, L.L.C. | 59 | $1,112 |
| Mallinckrodt Hospital Products Inc. | 36 | $780 |
| Lilly USA, LLC | 36 | $637 |
| ANI Pharmaceuticals, Inc. | 14 | $449 |
| Aurinia Pharma U.S., Inc. | 12 | $377 |
| Radius Health, Inc. | 23 | $342 |
| Genentech USA, Inc. | 20 | $335 |
| Medexus Pharma, Inc. | 13 | $308 |
| Organon | 17 | $240 |
| Sanofi | 8 | $218 |
| Pacira Therapeutics, Inc. | 11 | $168 |
| Bristol Myers Squibb | 11 | $147 |
| Sandoz | 5 | $91 |
| Fresenius Kabi USA, LLC | 4 | $70 |
| Sobi, Inc | 2 | $51 |
| Mallinckrodt Enterprises LLC | 2 | $45 |
| Ultragenyx Pharmaceutical Inc. | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Genentech, Inc. | 1 | $25 |
| Medtronic | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Celltrion USA Inc. | 1 | $14 |
How this compares
$457,693 in reported general payments places this provider in the 95th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Birmingham
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- William KirbyBirmingham$2.3M
- Jordan VaughnBirmingham$1.6M
- Stefanie KrickBirmingham$527K
- Ashraf KhanBirmingham$215K
- Robert LewisBirmingham$201K
- David WynneBirmingham$180K
- Kevin RiggsBirmingham$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.